111 related articles for article (PubMed ID: 4439138)
1. Impaired tumor immunity resulting from antigen competition.
Glasgow AH; Cooperband SR; Mannick JA
Surg Forum; 1974; 25(0):119-21. PubMed ID: 4439138
[No Abstract] [Full Text] [Related]
2. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
3. Proceedings: Tumour immunity - cellular and humoral responses during tumour growth.
Baldwin RW; Embleton MJ; Price MR; Robins RA
Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139105
[No Abstract] [Full Text] [Related]
4. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
5. In vitro evidence that Vibrio Cholerae neuraminidase increases antigenicity of sarcoma cells.
Faraci RP; Ketcham AS
Surg Forum; 1974; 25(0):99-101. PubMed ID: 4439267
[No Abstract] [Full Text] [Related]
6. [Cellular immunity to tumor antigens].
Hellström KE; Hellström I
Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
[No Abstract] [Full Text] [Related]
7. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
8. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
Haba S; Kitagawa M
Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
[No Abstract] [Full Text] [Related]
9. Enhancement phenomenon.
Petrányi GG
Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
[No Abstract] [Full Text] [Related]
10. [Immune surveillance in neoplasms].
Schneeweiss U
Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030
[No Abstract] [Full Text] [Related]
11. [Cellular aspects of the induction of the immune response].
Cerottini JC
Schweiz Med Wochenschr; 1972 Aug; 102(33):1138-41. PubMed ID: 5066341
[No Abstract] [Full Text] [Related]
12. [Immunological phenomenons and cancer].
Burtin P
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):589-92. PubMed ID: 5050869
[No Abstract] [Full Text] [Related]
13. [Cellular immunity and serum factors in plasmocytomas in mice].
Lespinats G; Poupon MF; Kolb JP
Bull Cancer; 1972; 59(4):353-62. PubMed ID: 4668253
[No Abstract] [Full Text] [Related]
14. Cellular immunity and blocking antibodies to tumors.
Hellström I; Hellström KE
J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
[No Abstract] [Full Text] [Related]
15. Cellular formation of viriolytic antibody by mouse immunocytes: cytokinetics and specificity.
McAlack RF; Cerny J; Friedman H
J Immunol; 1971 Dec; 107(6):1752-65. PubMed ID: 4941115
[No Abstract] [Full Text] [Related]
16. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
17. Immunological enhancement.
Russell PS
Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
[No Abstract] [Full Text] [Related]
18. [Tumor immunology in respect to cell-mediated destruction of target cells (author's transl)].
Hashimoto Y
Tanpakushitsu Kakusan Koso; 1973 Apr; 18(4):308-15. PubMed ID: 4594271
[No Abstract] [Full Text] [Related]
19. Introduction: interaction of humoral and cellular mechanisms in tumor immunity.
Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():221-2. PubMed ID: 4667436
[No Abstract] [Full Text] [Related]
20. [Immunology of tumors].
Barboni F; Rovinetti C
G Clin Med; 1974 Mar; 55(3):250-6. PubMed ID: 4430420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
